WO2008043533A3 - Acylaminoimidazoles et acylaminothiazoles - Google Patents
Acylaminoimidazoles et acylaminothiazoles Download PDFInfo
- Publication number
- WO2008043533A3 WO2008043533A3 PCT/EP2007/008789 EP2007008789W WO2008043533A3 WO 2008043533 A3 WO2008043533 A3 WO 2008043533A3 EP 2007008789 W EP2007008789 W EP 2007008789W WO 2008043533 A3 WO2008043533 A3 WO 2008043533A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acyl
- aminoimidazoles
- aminothiazoles
- diseases
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002666177A CA2666177A1 (fr) | 2006-10-11 | 2007-10-10 | Acylaminoimidazoles et acylaminothiazoles |
JP2009531766A JP2010505896A (ja) | 2006-10-11 | 2007-10-10 | アシルアミノイミダゾール類およびアシルアミノチアゾール類 |
EP07818862A EP2079708A2 (fr) | 2006-10-11 | 2007-10-10 | Acylaminoimidazoles et acylaminothiazoles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006048042.2 | 2006-10-11 | ||
DE102006048042A DE102006048042A1 (de) | 2006-10-11 | 2006-10-11 | Acylaminoimidazole und Acylaminothiazole |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008043533A2 WO2008043533A2 (fr) | 2008-04-17 |
WO2008043533A3 true WO2008043533A3 (fr) | 2008-07-03 |
Family
ID=39184814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/008789 WO2008043533A2 (fr) | 2006-10-11 | 2007-10-10 | Acylaminoimidazoles et acylaminothiazoles |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2079708A2 (fr) |
JP (1) | JP2010505896A (fr) |
CA (1) | CA2666177A1 (fr) |
DE (1) | DE102006048042A1 (fr) |
WO (1) | WO2008043533A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2350002A1 (fr) | 2008-10-02 | 2011-08-03 | Abbott Laboratories | Nouveaux composés utilisés comme bloqueurs des canaux calciques |
WO2011115813A1 (fr) | 2010-03-18 | 2011-09-22 | Abbott Laboratories | Acétamides de lactame en tant que bloqueurs des canaux calciques |
JP2015083542A (ja) * | 2012-02-08 | 2015-04-30 | 大日本住友製薬株式会社 | 3位置換プロリン誘導体 |
IN2014MU00072A (fr) * | 2014-01-08 | 2015-08-21 | Wockhardt Ltd | |
PT3762368T (pt) | 2018-03-08 | 2022-05-06 | Incyte Corp | Compostos de aminopirazina diol como inibidores de pi3k-y |
WO2020010003A1 (fr) | 2018-07-02 | 2020-01-09 | Incyte Corporation | DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004009565A2 (fr) * | 2002-07-17 | 2004-01-29 | Sanofi-Aventis | Derives d'acylaminothiazole, leur utilisation comme inhibiteurs de beta-amyloi |
WO2005092864A1 (fr) * | 2004-03-23 | 2005-10-06 | Pfizer Products Inc. | Composes d'imidazole destines au traitement de troubles neurodegeneratifs |
WO2007082666A1 (fr) * | 2006-01-12 | 2007-07-26 | Bayer Healthcare Ag | Acylaminoimidazoles |
-
2006
- 2006-10-11 DE DE102006048042A patent/DE102006048042A1/de not_active Withdrawn
-
2007
- 2007-10-10 CA CA002666177A patent/CA2666177A1/fr not_active Abandoned
- 2007-10-10 EP EP07818862A patent/EP2079708A2/fr not_active Withdrawn
- 2007-10-10 WO PCT/EP2007/008789 patent/WO2008043533A2/fr active Application Filing
- 2007-10-10 JP JP2009531766A patent/JP2010505896A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004009565A2 (fr) * | 2002-07-17 | 2004-01-29 | Sanofi-Aventis | Derives d'acylaminothiazole, leur utilisation comme inhibiteurs de beta-amyloi |
WO2005092864A1 (fr) * | 2004-03-23 | 2005-10-06 | Pfizer Products Inc. | Composes d'imidazole destines au traitement de troubles neurodegeneratifs |
WO2007082666A1 (fr) * | 2006-01-12 | 2007-07-26 | Bayer Healthcare Ag | Acylaminoimidazoles |
Also Published As
Publication number | Publication date |
---|---|
DE102006048042A1 (de) | 2008-04-17 |
EP2079708A2 (fr) | 2009-07-22 |
JP2010505896A (ja) | 2010-02-25 |
WO2008043533A2 (fr) | 2008-04-17 |
CA2666177A1 (fr) | 2008-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008104306A3 (fr) | Amides de 4-aryl-1,4-dihydro-1,6-naphthyridine substitués et utilisation de ceux-ci | |
WO2009068214A3 (fr) | Pipéridines à substitution hétéroaryl | |
EP2022806A4 (fr) | Procédé pour la production de copolymères réticulés, copolymères réticulés obtenus par le procédé et utilisation de ceux-ci | |
WO2008155069A3 (fr) | Oxazolidinones substituées et leur utilisation | |
IL185804A0 (en) | Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments | |
WO2008113469A8 (fr) | Imidazopyrimidines et triazolopyrimidines substituées | |
WO2008046581A3 (fr) | Composés tétrahydropyrrolopyrazine substitués et leur utilisation dans des médicaments | |
SI2044076T1 (sl) | Postopek za pripravo azenapina in vmesni produkti, uporabljeni v tem postopku | |
IL220682A0 (en) | 1h-quinazoline-2,4-diones, processes for their manufacture, and use thereof in the preparation of medicaments for treating conditions mediated by the ampa-receptor | |
WO2008060877A3 (fr) | Dispositifs médicaux et procédés associés | |
EP2096191A4 (fr) | Produit moulé en copolymère d'éthylène et de tétrafluoroéthylène et son procédé de production | |
WO2007088034A3 (fr) | Traitement de la sclerose tubereuse | |
HK1110306A1 (en) | Crude glycerol-based product, process for its purification and its use in the manufacture of dichloropropanol | |
IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
EP2090310A4 (fr) | Procédés destinés à prévenir la coloration dans une préparation d'adhésif cutané contenant du donépézil, procédés de réduction de la production d'analogue de donépézil dans une préparation d'adhésif cutané | |
WO2010078900A3 (fr) | Nouvelles pyrazolopyridines à substitution aliphatique et leur utilisation | |
EP2052847A4 (fr) | Presse asservie et son procédé de commande | |
EP2067597A4 (fr) | Produit moulé par injection décoratif bosselé et son procédé de fabrication | |
LT1928255T (lt) | Pieno produktų gamybos būdas, tuo būdu gauti produktai ir jų panaudojimas | |
AU2007243282A8 (en) | Compositions and methods for the treatment of cardiovascular disease | |
EP2019133A4 (fr) | MICROORGANISME CAPABLE DE PRODUIRE DE L'ACIDE POLY-gamma-L-GLUTAMIQUE (gamma-L-PGA), PROCÉDÉ DE PRODUCTION DE gamma-L-PGA À L'AIDE DE CE MICROORGANISME, PRODUIT RÉTICULE ET AGENT POUR APPLICATION EXTERNE SUR LA PEAU | |
WO2008043533A3 (fr) | Acylaminoimidazoles et acylaminothiazoles | |
IL190585A0 (en) | Method for the diagnosis of thromboembolic and coronary heart diseases | |
WO2008019782A3 (fr) | Dispersions d'agents contenant des nanoparticules d'urée | |
ZA200902899B (en) | Product and process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2007818862 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2666177 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2009531766 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07818862 Country of ref document: EP Kind code of ref document: A2 |